Portage Biotech Inc.
PRTG
$5.42
-$0.54-9.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -24.91% | -16.31% | -23.58% | -16.25% | -27.38% |
| Depreciation & Amortization | -35.19% | -7.32% | 59.26% | 325.00% | 5,300.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -59.36% | -51.51% | -40.28% | -7.50% | 10.79% |
| Operating Income | 59.36% | 51.51% | 40.28% | 7.50% | -10.79% |
| Income Before Tax | 92.11% | 82.51% | 39.45% | 34.48% | 29.87% |
| Income Tax Expenses | 99.97% | 100.00% | 31.22% | 32.68% | 40.93% |
| Earnings from Continuing Operations | 91.01% | 79.43% | 40.45% | 34.73% | 27.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -74.42% | 32.69% | 5.41% | -73.49% | -21.82% |
| Net Income | 91.02% | 79.45% | 40.47% | 34.67% | 27.98% |
| EBIT | 59.36% | 51.51% | 40.28% | 7.50% | -10.79% |
| EBITDA | 59.43% | 51.61% | 40.42% | -16.81% | -108.33% |
| EPS Basic | 92.26% | 82.40% | 50.69% | 45.25% | 39.20% |
| Normalized Basic EPS | 65.21% | 90.76% | 68.68% | 37.36% | 20.73% |
| EPS Diluted | 92.26% | 82.40% | 50.69% | 45.28% | 39.24% |
| Normalized Diluted EPS | 65.21% | 90.76% | 68.68% | 37.36% | 20.73% |
| Average Basic Shares Outstanding | 22.31% | 21.44% | 20.75% | 17.20% | 20.02% |
| Average Diluted Shares Outstanding | 22.31% | 21.44% | 20.75% | 17.20% | 20.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |